Both HIV-infection and long-term antiretroviral therapy are associated with increased common carotid intima-media thickness in HIV-infected adolescents and young adultsspi

Current HIV Research

Volumn 8, Issue 5, 2010, Pages 411-417

  Vigano, Alessandra ^a   Bedogni, Giorgio ^b   Cerini, Chiara ^a   Meroni, Luca ^a   Giacomet, Vania ^a   Stucchi, Sara ^a   Fabiano, Valentina ^a   Coletto, Sonia ^a   Catalano, Mariella ^c   Minola, Marzio ^c   Zuccotti, Gian Vincenzo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Liver Research Center   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Antiretroviral therapy; Children; Cross sectional study; Hiv; Intima media thickness

Indexed keywords

CD36 ANTIGEN; DIDANOSINE; EMTRICITABINE; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LAMIVUDINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR DISOPROXIL; TRIACYLGLYCEROL; ZIDOVUDINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; DRUG EXPOSURE; FEMALE; FOLIC ACID BLOOD LEVEL; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LONG TERM CARE; MALE; MEAN ARTERIAL PRESSURE; PREDICTION; PROTEIN EXPRESSION; SEX DIFFERENCE; TREATMENT DURATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CASE-CONTROL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS; TUNICA INTIMA; YOUNG ADULT;

EID: 77954751118     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016210791330419     Document Type: Article

References (43)

1. Judd A, Doerholt K, Tookey PA, et al. Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care. Clin Infect Dis 2007; 45: 918- 24.
2. Viganò A, Giacomet V, Pattarino G, Fasan S, Zuccotti GV, Brambilla P. Metabolic complications of HIV infection and its therapy in children. Future HIV Therapy 2007; 1: 181-90.
3. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338: 1650-6.
4. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006; 37: 87- 92.
5. Chambless LE, Folsom AR, Clegg LX, et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000; 151: 478-87.
6. Lentz SR. Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost 2005; 3: 1646-54.
7. Durga J, Verhoef P, Bots ML, Schouten E. Homocysteine and carotid intima-media thickness: a critical appraisal of the evidence. Atherosclerosis 2004; 176: 1-19.
8. Silverstein RL, Febbraio M. CD36 and atherosclerosis. Curr Opin Lipidol 2000;11: 483-91.
9. Febbraio M, Podrez EA, Smith JD, et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 2000; 105: 1049-56.
10. Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 2001;108: 785-91.
11. Serghides L, Nathoo S, Walmsley S, Kain KC. CD36 deficiency induced by antiretroviral therapy. AIDS 2002; 16: 353-58.
12. Ibrahimi A, Abumrad NA. Role of CD36 in membrane transport of long-chain fatty acids. Curr Opin Clin Nutr Metab Care 2002; 5: 139-45.
13. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign, IL: Human Kinetics Books; 1988.
14. World Health Organization. Measuring Obesity: Classification and Distribution of Anthropometric Data. Report on a WHO consultation on epidemiology of obesity. Warsaw 21-23 October 1987. Copenhagen: World Health Organization Regional Office for Europe; 1989.
15. Children NHBPEPWGOHBPI, Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114.
16. Meaney E, Alva F, Moguel R, Meaney A, Alva J, Webel R. Formula and nomogram for the sphygmomanometric calculation of the mean arterial pressure. Heart 2000; 84: 64.
17. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-95. CCIMT in HIV-Infected Adolescents
18. Smilde TJ, Wollersheim H, Van Langen H, Stalenhoef AF. Reproducibility of ultrasonographic measurements of different carotid and femoral artery segments in healthy subjects and in patients with increased intima-media thickness. Clin Sci (Lond) 1997; 93: 317-24.
19. Salonen R, Haapanen A, Salonen JT. Measurement of intima- media thickness of common carotid arteries with high-resolution B- mode ultrasonography: inter- and intra-observer variability. Ultrasound Med Biol 1991; 17: 225-30.
20. Gepner AD, Korcarz CE, Aeschlimann SE, et al. Validation of a carotid intima-media thickness border detection program for use in an office setting. J Am Soc Echocardiogr 2006; 19: 223-8.
21. Bland JM, Altman DG. Transforming data. BMJ 1996; 312: 770.
22. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989; 45: 255-68.
23. Lin LI. A Note on the Concordance Correlation Coefficient. Biometrics 2000; 56: 324-5.
24. Royston P, Sauerbrei W. Multivariable model-building: a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables. Chichester, England; Hoboken, NJ: John Wiley; 2008.
25. Zimmet P, Alberti KG, Kaufman F, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 2007; 8: 299-306.
26. Jourdan C, Wühl E, Litwin M, et al. Normative values for intima- media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 2005; 23: 1707-15.
27. Sabin CA, Worm SW, Weber R, et al. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV- infected patients enrolled in the D: A: D study: a multi-cohort collaboration. Lancet 2008; 371: 1417-26.
28. McComsey GA, O'Riordan M, Hazen SL, et al. Increased carotid intima media thickness and cardiac biomarkers in HIV infected children. AIDS 2007; 21: 92127.
29. Lee AJ, Mowbray PI, Lowe GD, et al. Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery Study. Circulation 1998; 97: 1467-73.
30. McGill HC, McMahan CA, Herderick EE, et al. Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr 2000; 72: 1307S-15S.
31. Järvisalo MJ, Jartti L, Näntö-Salonen K, et al. Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation 2001; 104: 2943-7. Current HIV
32. Järvisalo MJ, Putto-Laurila A, Jartti L, et al. Carotid artery intima- media thickness in children with type 1 diabetes. Diabetes 2002; 51: 493-498.
33. Jericó C, Knobel H, Calvo N, et al. Subclinical carotid atherosclerosis in HIV-infected patients: role of combination antiretroviral therapy. Stroke 2006; 37: 812-7.
34. Johnsen S, Dolan SE, Fitch KV, et al. Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome. J Clin Endocrinol Metab 2006; 91: 4916-24.
35. Currier JS, Kendall MA, Henry WK, et al. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS 2007; 21: 1137-45.
36. Mangili A, Gerrior J, Tang AM, et al. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score. Clin Infect Dis 2006; 43: 1482-9.
37. Lorenz MW, Stephan C, Harmjanz A, et al. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis 2008; 196: 720-6.
38. Charakida M, Donald AE, Green H, et al. Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy. Circulation 2005; 112: 103-9.
39. Giuliano Ide C, de Freitas SF, de Souza M, Caramelli B. Subclinic atherosclerosis and cardiovascular risk factors in HIV-infected children: PERI study. Coron Artery Dis 2008; 19: 167-72.
40. De Villiers WJ, Smart EJ. Macrophage scavenger receptors and foam cell formation. J Leukoc Biol 1999; 66: 740.
41. Meroni L, Riva A, Morelli P, et al. Increased CD36 expression on circulating monocytes during HIV infection. J Acquir Immune Defic Syndr 2005; 38: 310-3.
42. Meroni L, Giacomet V, Morelli P, et al. Increased CD36 expression in vertically human immunodeficiency virus-infected children unrelated to antiretroviral therapy. Pediatr Infect Dis J 2005; 24: 576-7.
43. Chantry CJ, Hughes MD, Alvero C, et al. Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy. Pediatrics 2008; 122: e129-e138